Abstract
BackgroundB cell depletion with rituximab is effective for reducing the symptoms and inhibiting the progression of joint damage in patients with rheumatoid arthritis (RA). However, the use of peripheral B...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
